Women's Fem Dophilus

Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.

Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.

Keep out of reach of children.

Keep refrigerated.

Free of major allergens.

Suitable for Vegetarians/Vegans.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

2018 Jarrow Formulas

Gluten free

05318FEM PROD # 103005

Oral Probiotic Supplement

Vaginal/Urinary Tract Health

Now in veggie cap!

No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.

Strains Matter Jarrow Formulas' Probiotic Contain Clinically Documented Strains

GR-1/RC-14 and vaginal flora (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement GR-1/RC-14 75% Control Group 34% Martinez, et al. Cal J Microbiol 2009;55:133-138 25+ years of GR-1/RC-14 Research/clinical studies 1988 First Research on GR-1/RC-14 Strains begin 27 Clinical Studies Published Between 2001 and 2014 2006 Fem-Dophilus Introduced (2006)

If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

Fem-Dophilus contains two patented and clinically documented probiotics strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote vaginal and urinary tract health.

A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.

25+ years of research/clinical studies

Patented strains Lactobacillus Rhamnosus, GR-1 and Lactobacillus Reuteri, RC-14

Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date.

RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S.

Vegan V Veggie Caps V

Made in Denmark by Chr. Hansen A/S